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Abstract  
Proctitis is an inflammation involving the anus and the distal part of the rectum, frequently diagnosed 
in the context of inflammatory bowel diseases (IBD). Nevertheless, when the standard therapy for 
IBD is ineffective, it becomes necessary for the clinician to review alternative etiologies, beginning 
from the broad chapter of infectious causes up to rare causes such as radiation, ischemia, diversion 
and traumatisms. While it is possible to find infectious proctitides caused by pathogens generally 
inducing extensive colitis, the growing incidence of both sexually transmitted infections and isolated 
proctitis reported in the recent years require a lot of attention. The risk appears to be higher in 
individuals participating in anal intercourse, especially men having sex with men (MSM) or subjects 
who use sex toys and participate to sex parties, dark rooms and so on. The commonest implicated 
pathogens are Neysseria gonorrhoeae, Chlamydia trachomatis, Herpes Simplex virus and Treponema 
pallidum. Herpes and Chlamydia infections mainly occur in HIV-positive MSM patients. Since 
symptoms and signs are common independently from etiology, performing a differential diagnosis 
based on clinical manifestations is complicated. Therefore, the diagnosis is supported by the 
combination of clinical history and physical examination and, secondly, by endoscopic, serologic and 
microbiologic findings. Particular emphasis should be given to simultaneous infections by multiple 
organisms. The involvement of experts in infectious diseases and in sexual health is crucial for the 
diagnostic and therapeutic management. The available therapies, empirically initiated or specific, in 
many cases are able to guarantee a good prognosis and to prevent relapses. 
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Proctitis is an inflammation confined to the distal 12-15 cm of the rectum. The most common type is 
part of chronic inflammatory bowel diseases (IBD), conditions of unknown etiology including 
Crohn’s disease and ulcerative colitis1 and presenting with rectal bleeding, diarrhea, tenesmus, 
discharge, cramps and pain on the left side of the abdomen during the bowel movement. Proctitis as 
part of IBD has a good response to topical and oral therapy with 5-aminosalicylic acid (5-ASA) and/or 
prednisone, but it may also have a more aggressive course, especially in the context of Crohn’s disease 
of the ano-rectal region, so that a therapy with biological drugs or immune-modulators could be 
required.2,3 
   Despite these well-known aspects of IBD, it is necessary to emphasize how proctitis could be 
ascribed to other causes, infectious and not. It is not rare, for clinicians, to deal with clinical cases 
having an initial diagnose of IBD but over time not responder to standard therapy and, therefore, 
requiring a good attitude to take into consideration other etiologies. 
   Considering infectious etiologies, this review highlights on the main pathogens acting in the 
rectum as a prevalent or exclusive site. Among non-infectious causes, those due to radiation 
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Table 1. Etiology of proctitis. 
 
 
INFECTIOUS NON INFECTIOUS 
1. Sexually transmitted pathogens 
(isolated proctitis) 
• Neysseria gonorrhoeae  
• Clamydia trachomatis 
• Herpes Simplex virus 
• Treponema pallidum 
• Haemophylus ducreyi 
• Cytomegalovirus 
2. Sexually and non sexually transmitted 
pathogens (extended colitis) 
• Campylobacter jejuni, Shigella, 
Entamoeba histolytica, Giardia 
lamblia and others. 
• Inflammatory bowel diseases 
• Radiation therapy 
• Ischaemia 
• Surgical diversion 




Clinical and endoscopic findings in patients with proctitis 
 
   Regardless of the specific etiology, the clinical pictures and endoscopic characteristics are often 
superimposable in patients with proctitis, so further investigation are needed to trace the exact cause, 
as it will be explained below. Peculiar symptoms include: diarrhea (mild or severe), urgency, 
tenesmus, cramping pain during bowel movements, mild/severe rectal bleeding, hematochezia, 
involuntary spasms, pruritus, anorectal discharge (pus), anal warts and the feeling of incomplete 
emptying of the bowel. Endoscopic findings associated with acute injury include edema, erythema, 
friability and mucosal ulceration, while, in the chronic cases, distinctive findings are nodules, 
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Sexually transmitted pathogens 
   In several cases it is essential to take into consideration pathogens which are specifically responsible 
of isolated proctitis. In the last years, indeed, there has been a rising incidence, especially in men have 
sex with men (MSM), of sexually transmitted infections (STIs), which can have proctitis as the main 
manifestation. This often occurs in healthy patients presenting with rectal symptoms, so that 
gastroenterologists or other specialists dedicated to proctology are required to have an adequate 
knowledge of the potential etiological agents in order to guide the proper approach and a successful 
therapeutic intervention.  
   It is unavoidable to collect a detailed and careful clinical history regarding recent traveling history 
and also risk behaviors, such as anal intercourse and number of sexual partners. The most frequent 
agents of infectious proctitides are represented by Neysseria gonorrhoeae (N. gonorrhoeae), 
Chlamydia trachomatis (C. trachomatis), Herpes Simplex virus (HSV) and Treponema pallidum (T. 
pallidum). In about a half of cases the infectious cause is not identifiable.4 Furthermore, should be 
considered the possibility to find coinfections with two or more pathogens (10% of all cases). Once 
an infectious proctitis is diagnosed, all STI sample testing, including human immunodeficiency virus 
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(HIV), are mandatory. In case of suspicious of a STI, patients must be submitted to a STI Clinic to 
assess all possible sexually transmitted co-infections.   
Neysseria Gonorrhoeae  
 
   N. gonorrhoeae represents the most frequent bacterial cause of infectious proctitis and the second 
most prevalent STIs in the United States; however, the actual number of cases is likely much higher 
due to asymptomatic infections or self administered therapy.5,6 N. gonorrhoeae is a Gram-negative 
bacterium, facultative intracellular, obligate aerobe and able to move with twitching motility. It 
typically appears in pairs, diplococci, and resembles the shape of coffee beans. The way of 
transmission is by direct contact of mucosal surfaces, and so gonorrhea is commonest in individuals 
participating in receptive anal intercourse, typically in MSM,7-9 while in females it can be transmitted 
to the anal canal via a genital infection due to the proximity of the vagina, even in the absence of 
receptive anal intercourse.  
   The most typical symptoms, not allowing alone to achieve a differential diagnosis from other 
infectious causing proctitis, occur after 5-7 days of incubation and include tenesmus, rectal bleeding, 
pruritus, lower abdominal pain, diarrhea and anorectal purulent discharge. In a small part of cases this 
infection can be asymptomatic.10 
   Due to the lack of sensitivity and specificity of the clinical diagnosis it is necessary to proceed to a 
microbiological diagnosis. The test of choice is NAAT (Nucleic Acid Amplification Testing, eg. 
polymerase chain reaction or PCR) which is the most sensitive. If this method is unavailable it is 
possible to evaluate the presence of Gram-negative diplococci in Gram stain of mucosal biopsies or 
purulent discharge, with a sensitivity of 90–95%,11 or with culture executed on Thayer-Martin agar, 
which prevents the overgrowth of other endogenous flora. Appropriate material for culture should be 
obtained using a swab through the anal canal into the distal rectum or under direct vision via 
proctoscopy.10 Culture has the advantage to assess antibiotic susceptibilities but the results are not 
usually available until 48 hours: its sensitivity is 72-95%, declining in asymptomatic patients to 65-
85%.12 When no specific diagnostic test is available, the diagnosis of gonorrhea remains presumptive.  
   Rectal gonorrhea should be treated with ceftriaxone 250 mg intramuscularly (i.m.) in a single dose, 
alongside oral azithromycin 1 g once. Alternatives oral antibiotics can be cefixime 400 mg once daily 
or doxycycline 100 mg once daily for 7-10 days.13 Gonorrhea is becoming increasingly resistant to 
cephalosporins and so it is better to verify eradication by repeating testing at the end of treatment in 
























































Page 6 of 32
improve eradication of the bacterium and allows to slow down the development of further 
cephalosporin resistance. Differential diagnosis must be performed with other STI but also with 
criptitis and anal abscess.  
 
Fig. 1. Anal cryptitis caused by N. gonorrhoeae. 
 
Chlamydia trachomatis  
 
   C. trachomatis belongs to a group of obligate intracellular parasites of eukaryotic cells which can 
replicate only within a host cell. It has a life cycle consisting of two morphologically distinct forms: 
firstly C. trachomatis attaches to a new host cell as a small spore-like form, called elementary 
body,  which penetrates the host cell, surrounded by a host vacuole, called inclusion. Within the 
inclusion, C. trachomatis turns into a bigger and more metabolically active form called reticulate 
body.14  
   C. trachomatis serotypes L1, L2 and L3 are the responsible pathogens for “linfogranuloma 
venereum (LGV)” and especially serotype L2 has been reported to be mostly implicated,15,16 while 




1. Linfogranuloma Venereum  
 
   LGV, also known as "Durand–Nicolas–Favre disease” and "lymphogranuloma inguinale" is 
an uncommon sexually transmitted disease (STD). The ways of transmission are vaginal, oral or anal 
sex. In the last 20 years the incidence of LGV has shown a remarkable increase in Europe and North 
America but it still remains more common in the tropical and subtropical regions around the world.17 
The highest incidence of LGV occurs in the sexually active population between 15 and 40 years. LGV 
probably affects both sexes equally, although it is more commonly reported in MSM,18 in whom 
emerges as a leading cause of proctitis and proctocolitis.19 It is important to emphasize that LGV 
patients are frequently HIV-positive MSM with proctitis (85%) and approximately 50% carry other 
STIs.20 
   LGV has different stages of infection: a primary stage characterized by the appearance of painless 
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with the development of unilateral or bilateral tender inguinal and/or femoral lymphadenopathy (also 
called “buboes”). In the secondary stage, symptoms of infection are local, such as tenesmus, anal 
pain, mucous and bloody rectal discharge, but also systemic like body aches, headache, and fever. In 
a quarter of the cases patients manifest only rectal symptoms without the development of a 
lymphoadenopathy.21  
   Longstanding LGV can lead to a late stage of the disease with the development of fibrosis, strictures 
and fistulae of the ano-genital area, findings which can mimic histological, endoscopical and 
radiological views of IBD or anal cancer.22  
 Currently, a definitive diagnosis  of LGV is based on serological tests as complement fixation titers > 
1:64 or micro-immunofluorescence titers > 1:256.19, 23 However, the interpretation of these tests have 
not been yet standardized or validated for rectal infections so that, in most circumstances, the 
diagnosis of LGV is based on epidemiological and clinical findings with the supports of methods of 
identification of C. trachomatis in genital, rectal and lymph node specimens like culture (although it 
is difficult and requires a special medium, cycloheximide-treated McCoy or HeLa cells, and yields 
are still only 30-50%), NAAT or direct immunofluorescence of rectal swabs or lymph node aspirate.17 
Since this has implications for the duration of treatment, genotyping might be required as an 
additional test to distinguish LGV from non-LGV. HIV testing should be a consideration in patients 
with a STD. 
   Treatment, based on the clinical experience of more than 50 years, considers, as first line, a course 
of doxycycline 100 mg twice daily for 3 weeks.13, 24-26 This duration is mandatory because these 
infections are more invasive and harder to eradicate than uncomplicated genito-urinary tract 
infections, which generally require only 1 week of treatment. A valid alternative is represented by 
oral erythromycin 500 mg four times daily for 3 weeks, although its use can be limited by 
gastrointestinal intolerance. This option is recommended for pregnant women,27 while doxycycline 
and other tetracyclines should be avoided in pregnancy due to the risk of disruption of bone and teeth 
development. Despite the lack of clinical evidence supporting the routine use of azithromycin, it could 
also be effective as additional option for treating LGV, given its efficacy against other genital tract 
and systemic non-LGV Chlamydia infections. Fluoroquinolone antibiotics with demonstrated anti-
Chlamydia activity, such as levofloxacin, ofloxacin, moxifloxacin, may also be useful for treating 
LGV, but no comparative treatment trial has been published. Treatment of asymptomatic rectal 
Chlamydia infections is still controversial.28 Asymptomatic sexual partners should also be treated 
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Fig. 2. Linfogranuloma Venereum. 
 
 
1. Non-LGV Chlamydial proctitis 
 
   C. trachomatis serovars A–K are responsible for the non-LGV infections. Transmission is similar 
to that of N. gonorrhoeae and the infection may occur after anal receptive intercourse. Symptoms 
usually appear 7–10 days after infection and, in over 50% of cases registered in MSM, they are limited 
to the anal area, without urethral infection. They consist of anal pain, diarrhea, tenesmus, blood and 
mucous discharge and, sometimes, generalized symptoms as fever. The infection can also be 
asymptomatic in up to 50-70 % of patients.29 
   Sigmoidoscopy can show findings difficult to distinguish from IBD: friability and erythema of the 
mucosa with ulcerations and a “cobblestone” appearance for the infiltration of underlying lymphoid 
follicles. Histological examination can reveal granulomas, another non-specific finding generating 
confusion with IBD.  
   Microbiological diagnosis is based on culture or NAAT on rectal swabs. NAAT has been estimated 
to have a sensitivity of about 90% and a specificity of about 99% in cervical swab and by urine 
specimen30 but recent evidences indicates that it may give reliable results on rectal specimens. 
Moreover, it could be useful to analyze with Aptima combo 2 (Hologic Gen-Probe) that is a 
transcription mediated assay with the advantage of detecting both N. gonorrhoeae and C. 
trachomatis.31 
   Treatment of proctitis takes into consideration doxycycline 100 mg twice daily for 1 week. 
Alternatively, with comparable efficacy, it is possible to use azithromycin 1 g as a single dose32  
although up to 20% of failure has been observed and therefore it is recommended to repeat NAAT 
after 6 weeks from the end of treatment. It is advisable to start the same therapy in sexual partners 
and to consider the high risk of a co-infection with N. gonorrheae and, therefore, starting empiric 
treatment against the latter in patients with non-LGV C. trachomatis infection. 
 
Herpes simplex virus 
 
   Herpes simplex virus (HSV) is one of the most known and widespread infections in humans, 
involving about 60-95% of the adult population worldwide, more than 400 million persons.33,34  
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HSV infection has been involved in several diseases.35,36 Therefore, its constant epidemiologic 
monitoring is considered of high relevance for public health in order to decrease the risk of neonatal 
HSV infection and associated diseases.37 Seroprevalence for HSV-1 is present in 93% of the adult 
population but seroprevalence of HSV-2 is lower, confined to 5.5% in adults38 and frequently 
associated with other STDs. In US, according to the US Centers for Disease Control and Prevention, 
it has been reported a seroprevalence, in the years 2005-2008, of 16.2%.16 
   The two types of HSV, HSV-1 and HSV-2, are both DNA viruses transmitted by direct contact with 
infected secretions. HSV-1 is generally associated to infections manifesting around labial, oral, and 
ocular areas, while HSV-2 is associated to lesions around ano-genital area. However, it is frequent to 
have overlap infections and recent studies demonstrated an increase in ano-genital manifestations due 
to HSV-1, primarily in developed countries and probably secondary to a greater diffusion of oro-
genital sex practices, especially in MSM.39,40 HSV is second only to N. gonorrhoeae as a sexually 
transmitted cause of infectious proctitis in MSM.41,42 Moreover, in a recent review, it was postulated 
a leading role for HSV in causing proctitis in HIV-infected patients.43 
   Once the virus has entered the host, HSV creates a persistent and latent infection: in fact, it remains 
in a dormant state inside the neuronal ganglia, near the spinal cord, and periodically reactivates, 
travelling through the nerve fibers back to the skin, causing symptoms again. Recurrence has been 
reported to occur in about 60% of those infected with HSV-1 and in 90% of those with HSV-2.11  
   HSV-2 is transmitted by anal receptive intercourse and risk factors for contracting infection include: 
greater lifetime number of sexual partners, female sex, older age, poverty, cocaine use.44 Primary 
HSV infection may be asymptomatic, but 40% of men and 70% of women will develop systemic 
features including general malaise, headaches and muscle pains. HSV-associated proctitis appears 7-
21 days after exposure and includes the following symptoms: tenesmus, anorectal pain, rectal 
bleeding, perianal ulcerations, diarrhea or constipation, inguinal lymphadenopathy and the presence 
of diffuse ulcerative or discrete vesicular or pustular lesions in the distal 5 cm of the rectum. Most 
individuals with HSV proctitis present neurologic involvement, in the distribution of sacral roots. 
This induces difficulty in initiating micturition, paresthesia of the buttock or perineal region or 
impotence, as reported in more than a half of the patients affected.45 Subsequently, the lesions evolve 
in crusts which are followed by healing after 2 weeks. After the start of antibody production to HSV-
2, the virus becomes latent and can be reactivated leading to a recurrence of proctitis. In the latter 
case, proctitis has a course that is milder in symptomology and decrease in frequency over time.13,16  
   Characteristic findings in sigmoidoscopy consist of mucopurulent exudates, friable mucosa, 
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because these findings are reported in only about 30% of the patients affected at the time of the 
diagnosis.40 
   Currently, PCR assays for HSV-DNA, viral cultures and direct fluorescent antibody (DFA) are 
commonly used for the diagnosis, with immunohistochemistry demonstrating to be one of the best 
tool among them. In fact, DFA is highly sensitive and specific and permits to distinguish between 
numerous viruses using specific monoclonal antibodies.44 In alternative, it is possible to use serology, 
with assays based on the HSV-specific glycoprotein G1 (HSV-1) and glycoprotein G2 (HSV-2) and 
can reliably distinguish HSV-1 from HSV-2.46 An historical test is the Tzanck smear of samples 
obtained by scraping of an ulcer base: it would permit diagnosis revealing multinucleated giant cells 
or intranuclear inclusion bodies. However, this test has a limited sensitivity and specificity and has 
been largely replaced by DFA. Treatment for the first clinical episode is based on a cycle of 7–10 
days with one of the following oral antiviral therapies: acyclovir 400 mg 3 times daily, acyclovir 200 
mg 5 times daily, valacyclovir 500 mg twice daily, famciclovir 250 mg 3 times daily.47 Pain control 
with local anesthetics and warm soaks could be useful as a supportive care. In immunosuppressed 
individuals or in case of frequent/severe recurrences it should be considered a long-term daily 
suppressive antiviral therapy to reduce the risk of further episodes of HSV proctitis.   
 
Treponema pallidum  
   Belonging to the spirochete group, T. pallidum is a pathogen causing an infectious disease called 
“syphilis”. Approximately 17.7 million individuals, 15–49 years of age, globally have contracted 
syphilis in 2012, with an estimated 5.6 million new cases every year.48,49 The estimated prevalence 
and incidence of syphilis varies by country, with the highest prevalence in Africa. In general, the 
incidence of syphilis both in men and women has risen in recent years, especially in MSM, and 
syphilis remains a continuing public health challenge globally.50 
   T. pallidum is an obligate human pathogen very invasive and immunoevasive,51,52 able to induce 
local inflammatory response by replicating within the tissue and so causing clinical manifestations. 
Transmission occurs during sexual contact with an actively infected partner and it has been reported 
that exudate containing as few as 10 organisms can transmit the infection and induce the disease.53  
   The typical course of the disease is divided into primary, secondary, latent and tertiary stage over a 
period of ≥10 years. Primary syphilis presents on average within 3 weeks of exposure (or better within 
30-90 days), with a painless solitary ulcer (chancre), indurated and with discharge serous fluid, and a 
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significant pain and itching can occur.16 A painless anal fissure is typical of anal infection. This could 
develop a proctitis. If unidentified, primary disease can evolve to secondary syphilis in 4–10 weeks 
(but up to 2 years) later, in which bacteremia leads to multisystem disease that may include a lot of 
clinical manifestations: maculopapular or pustular rash, peripheral neuropathy, hepatitis, periostitis, 
glomerulonephritis, meningitis, anterior uveitis and interstitial keratitis. The typical rash may form 
flat, broad, whitish, wart-like lesions on mucous membranes, covered in a greyish exudate, known as 
condilomata lata, papules commonly perianal or genital in anatomical origin. Condylomata lata are 
highly infectious. Tertiary syphilis may occur approximately 3-15 years after the initial infection, in 
one third of people who did not receive treatment, and may be distinguished into three different forms: 
gummatous syphilis (gummae are granulomatous nodules or ulcers of the gastrointestinal tract or 
buttocks), late neurosyphilis (dementia, paresis, seizures), and cardiovascular syphilis (aortitis or 
aneurisms).54  Up to 2 years after acquisition, early infection without any manifestations of the first 
two stages is defined as “early latent syphilis”. Primary, secondary and early latent stages of syphilis 
are infectious, whereas the later stages of tertiary syphilis are largely non-infectious. Therefore, the 
biggest efforts should focus on diagnosing and treating primary, secondary and early latent syphilis 
so as to avoid later complications. 
   A diagnosis of syphilis cannot be made by culture but by using dark ground microscopy and PCR 
of affected tissues as ulcer exudate, condylomata lata exudate or rectal biopsies. Blood tests are 
divided into non-treponemal and treponemal tests.55 Non-treponemal serologic tests are most 
commonly used to establish a diagnosis: venereal disease research laboratory (VDRL) and rapid 
plasma reagin (RPR) tests are used to diagnose an initial infection and to monitor response to therapy. 
False positives on the non-treponemal tests can occur with some viral infections, such 
as varicella and measles, but also with lymphoma, tuberculosis, malaria, pregnancy and some other 
conditions. Therefore, treponemal tests, such as treponemal pallidum particle agglutination (TPHA) 
or fluorescent treponemal antibody absorption (FTA-Abs) test, should be performed because are 
confirmatory and are required to identify false-positive VDRL or RPR tests. Antibodies may be 
undetectable within serum before 12 weeks from infection and so repeat blood sample 3 months after 
the last sexual risk may be necessary. As 40–60% of contactable sexual partners may be infected, 
contact tracing and screening are required.  
   Treatment of primary and secondary syphilis consists, as first line, of a single i.m. penicillin G 
benzathine 2.4 million units. This is a form of penicillin slowly hydrolysed to benzylpenicillin and it 
permits to improve bioavailability and better monitor. Alternatively, i.m. procaine penicillin 600.000 
units daily for 10–14 days can be given. In case of penicillin allergy, an alternative therapy is a 2-
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risk to develop it is substantially increased in case of HIV co-infection: 6.7% of MSM with an initial 
diagnosis of rectal syphilis experienced a recurrence within one year.56 
 
Fig. 3. Anal fissure and condilomata in syphilis. 
 
Fig. 4. Syphilitic proctitis. 
 
Haemophilus ducreyi  
 
   Haemophilus ducreyi (H. ducreyi) is a Gram-negative bacterium known as the causative agent of 
an ulcerating sexually transmitted disease called “chancroid”. Although this infection is rare and its 
incidence seems to be in decline, the true incidence of chancroid remains uncertain and 
underdiagnosed because few laboratories are able to correctly approach a microbiologic diagnosis.57 
H. ducreyi is transmitted by sexual contact through breaks in the skin during intercourse. Hours to 
days after exposure, infection manifests as tender papules with erythema that eventually goes into a 
pustule then an ulceration. The ulcers are typically painful and frequently multiple, but these features 
are not helpful to distinguish them from ulcers caused by other STDs. The most common site is the 
genitals, but perianal and anorectal region can be involved with abscesses and ulceration. In 50% of 
chancroid infections in men it is reported a painful unilateral inguinal adenopathy, which is rare in 
women.58 
   Diagnosis is based on culture on selective medium but PCR testing is more sensitive than culture 
for detecting H. ducreyi, although it is not widely available. Gram’s stain of material from the base 
of suspicious ulcers shows Gram-negative rods in small groups, with a sensitivity of 40-60%.58,59 
Treatment is with one of the following alternatives: oral azithromycin 1 g in single dose, ceftriaxone 
250 mg, i.m., in single dose,60 oral ciprofloxacin 100 mg twice daily for 3 days or oral erythromycin 





   Although most of the current guidelines on diagnosis and treatment of STIs do not consider 
extensively this etiology and although it is mostly considered in the context of proctocolitis, in HIV-
immunocompromised patients, some cases of Cytomegalovirus (CMV) isolated proctitis have been 
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associated with unprotected anal intercourse: the triad of mononucleosis like illness with rectal 
bleeding shortly after unprotected anal intercourse are considered as pathognomonic characteristics 
for sexually transmitted CMV proctitis. Peculiar findings on sigmoidoscopy are rectal mucositis and 
ulceration. CMV serology and biopsy (including CMV histochemistry) confirm the diagnosis. 
Suggestive histopathological findings include: enlarged cells with intracytoplasmic and intranuclear 
inclusion bodies.61 The role of antiviral therapy in primary CMV proctitis has not yet been defined as 
very often it spontaneously regresses. However, in patients at risk such as HIV-infected or 
immunocompromised, the therapy is necessary and is based on the use of gangiclovir and 
valganciclovir. CMV should be considered in any case of unexplained proctitis. 
 
 




   Considered as one of the most common causes of human gastroenteritis in the world, 
Campylobacter jejuni is a Gram-negative bacterium, appearing as curved or comma-shaped rods, able 
to move via flagella and typically surviving in environments with a low amount of oxygen. Food 
poisoning caused by its infection can be severely debilitating. In 2017, it has been described an 
increased incidence of culture-confirmed Campylobacter infections, till to 19.2 per 100,000 persons, 
the highest of all pathogens studied.62 Although in healthy patients the ingestion of contaminated food 
(raw or under-cooked poultry, raw dairy products) or water is the main way of transmission, some 
alternatives could exist. In fact, sexual transmission by practices promoting fecal-oral contact has 
been reported: Campylobacter species have been isolated from stool and rectal cultures obtained from 
homosexual individuals presenting with proctocolitis.58,62 The infection is characterized by an 
inflammatory, sometimes bloody diarrhea or dysentery, associated to cramps, fever, myalgias, chills 
and abdominal pain, which appear 1-3 days after the infection.63 The clinical manifestations can be 
confused with appendicitis or IBD. In HIV-positive patients it is frequent to observe a more severe 
course with bacteremia, due to its capability to spread in the blood, or with extraintestinal 
manifestations such as cellulitis and pneumonia.64 
   Usually, endoscopy offers non-specific findings of proctocolitis and is not useful for differential 
diagnosis. Stool culture is the most reliable tool for the diagnosis.  
   Treatment is necessary, especially in immunocompromised patients, and is based on azithromycin 
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individuals, the infection is self-limiting and, in most cases, symptomatic treatment by liquid and 




   In the genus Shigella are included Gram-negative pathogenic enterobacteria known to be the cause 
of bacillary dysentery (shigellosis). Shigellosis is due to the capacity to invade and colonize the 
colonic mucosa, particularly the rectosigmoid portion of the colon, leading to its disruption. The most 
frequent species are Shigella Flexneri (S. Flexneri) e Shigella Sonnei (S. sonnei). The transmission 
of Shigella can occur via contaminated food and water and via direct person-to-person spread, but in 
1974 its sexual transmission was first reported.65 Patients with shigellosis typically present with high 
fever, abdominal cramps, vomiting and bloody, mucoid or watery diarrhea. S. sonnei is usually 
associated to a mild course, in general watery diarrhea, S. flexneri commonly causes bloody 
diarrhea.66    
   Sigmoidoscopy shows a proctitis but inflammation may be extended proximally to the rectum. 
Diagnosis relies on the presence of erythrocytes, polymorphonuclear neutrophils (PMNs), and mucus 
in patient stools, which are considered as diagnostic elements. Nowadays, in most laboratories, 
automated PCR on stool is a commonly used test. In an immunocompetent host, the course of disease 
is generally self-limited, lasting no more than one week when left untreated.    
   Treatment consists of supportive care and symptomatic drugs (antimotility agents are 
contraindicated). Antibiotics can be used in immunocompromised patients and should be selected on 
the basis of regional antibiotic susceptibility profiles due to the high rate of antibiotic resistance. 
 
Entamoeba histolytica  
 
   Entamoeba histolytica (E. histolytica) is a protozoan that causes non-febrile intestinal infection, 
called amebiasis. Although it can occur worldwide, the prevalence is disproportionately higher in low 
and middle-income countries because of poor socioeconomic conditions and sanitation levels, while 
in developed countries, amebiasis is generally seen in migrants or travelers coming from endemic 
areas (Mexico, Latin America and Asia) after a long stay (it is not a common cause of travelers’ 
diarrhea). With over 100.000 deaths per year, it is the third most deadly parasitic infection.67 The most 
known way of transmission is the fecal-oral route but it can also be transmitted sexually, both in 
homosexual and heterosexual individuals.68 Risk factors for contracting this infection have been 
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E. histolytica infection is asymptomatic, but there are several factors which may determine the 
outcome such as genetic susceptibility, young age, corticosteroid or immunosuppressive treatments, 
malnutrition, malignancy and alcoholism.70 Amebiasis generally presents a subacute onset, symptoms 
appear after 1-3 weeks from ingestion of cysts, when trophozoites damage the mucosa causing an 
inflammatory infiltrate and proctocolitis. Diarrhea can range from mild to severe, with bloody stool, 
abdominal pain and weight loss, configuring a dysentery syndrome. In some case the course can be 
deleterious with a fulminant amebic colitis: bowel necrosis leads to perforation and peritonitis, 
conditions associated to a mortality rate higher than 40%.71  
   Diagnosis is well established by the combination of antigen testing (using monoclonal antibodies 
to bind specific epitopes in stool and serum) or serology together with identification of trophozoites 
or cysts on microscopic examination of stool specimens. Antibodies are detectable within 5-7 days of 
acute infection and may be result positive for years. Also molecular methods may be helpful and PCR 
techniques can detect E. histolytica in stool specimens. Endoscopy shows ulcers, erosions, exudates, 
edematous cecal mucosa or the common findings which are “flask-like” ulcerations or erosions 
typically present in the cecum, followed by the rectum and the other segments of the colon.72 
However, in the acute phase, colonoscopy should be avoided because of the risk of perforation due 
to the instillation of air necessary to expand and visualize the colon. 
   Treatment is based on nitroimidazole drugs as metronidazole 500 to 750 mg by mouth three times 
daily for 7-10 days or tinidazole 2 g once a day for 3-5 days.73 After a 10-day course of a 
nitroimidazole, paromycin (or, in second line, diiodohydroxyquin and diloxanide furoate) should be 
administered to assure that the luminal parasites are deleted and to prevent relapse.74 Promising results 
are coming from the investigation of vaccines in rodent and non-human primate models. 
 
Giardia Lamblia  
 
   Giardia Lamblia (G. Lamblia) is a flagellated protozoan parasite, etiological agent of giardiasis. 
More than 200 million cases of giardiasis are annually diagnosed worldwide, with a higher prevalence 
in developing countries. This parasite is transmitted via fecal-oral route (water is a major source of 
transmission) through direct or indirect ingestion of infectious cysts but, sexual transmission has been 
reported in MSM.75 Parasites penetrates the human organism adhering and replicating on the brush 
border of the duodenum and jejunum and feeding on the mucous secretions of the intestine. Clinical 
manifestations of infection have a wide spectrum, from the absence of symptoms to diarrhea, malaise, 
steatorrhea, abdominal cramps, bloating, flatulence, and nausea. Although rare, in some cases 
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   Direct stool microscopy may reveal trophozoites, expecially in liquid feces, while oocysts may be 
seen in either liquid or solid feces. Limitations of stool microscopy include intermittent excretion 
of Giardia cysts (necessitating up to three stool exams). Antigen detection assays and nucleic acid 
detection assays have been also developed for detecting Giardia. In some cases, duodenal biopsy or 
aspirate may be required to confirm the diagnosis. First line for treatment of giardiasis is based on 
metronidazole 400 mg three times daily for 5-10 days. Other effective treatments include tinidazole 
and nitazoxanide. Alternatives to these medications include paromomycin, mebendazole, albendazole 
and furazolidone.76 
 




   Radiation-associated proctitis is a complication after exposure to x-rays or other ionizing 
radiation used in the context of radiation therapy for pelvic tumors such as prostate, cervix, uterus, 
testicles, bladder, rectum, anal or for lymphoproliferative malignancies. Due to its topographic and 
fixed position in the pelvis, the rectum is highly exposed to damage from radiation therapy. This 
inflammation can be distinguished in two types, acute or chronic. Acute form, manifesting with the 
typical proctitis symptoms and endoscopic features, usually occurs within the first 3 months of 
radiation therapy and is often self-limiting. Chronic proctitis, generally occurs in patients who had 
suffered from severe acute proctitis, with the median interval of onset ranging between 8 and 13 
months.77 Sometimes it appears as chronic from the beginning, after 3 months of therapy completion. 
Among the risk factors for its development are included: diabetes mellitus, IBD, smoking, peripheral 
vascular disease, chemotherapy administration.78 Typical manifestations are rectal bleeding, 
tenesmus and symptoms of intestinal obstruction.  
   Mucosal friability, strictures, fistulas, spontaneous hemorrhage, teleangectasias and ulcerations are 
distinctive endoscopic features that explain the most reported symptoms. Biopsies, directed at the 
lateral and posterior walls to avoid the irradiated areas because of the risk of fistula formation, may 
be helpful in the differential diagnosis and show the presence of eosinophilic crypt abscesses, 
endothelial arteriole swelling and loss of mucosal cells in the acute form79,80 whereas arteriolar 
endarteritis, fibrosis of the lamina propria, crypt distortion, and Paneth cell metaplasia characterize 
the chronic form.  
   In absence of large clinical trials, the experiences on treatment are very limited. Three main 
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medical therapy which includes: enemas containing drugs with antinflammatory and antioxidant 
action and beneficial properties for epithelial microvascular injury (5-aminosalicylic acid, sucralfate, 
short-chain fatty acid, pentoxyfilline),81,82 oral antibiotics (metronidazole), topical applications and 
oxygen therapy. Endoscopic therapy includes dilation, laser, argon plasma coagulation (APC), 
cryotherapy, radiofrequency ablation, and mesenchymal stem cell therapy.83  
In a recent review focused on agents studied for the prevention and treatment of gastrointestinal 
mucositis (GIM), the evidence continues to support use of probiotics containing Lactobacillus spp. 
for prevention of chemoradiotherapy and radiotherapy-induced diarrhea in patients with pelvic 
malignancy, and hyperbaric oxygen therapy to treat radiation-induced proctitis. Additional well-
designed research is encouraged to enable a decision regarding palifermin, glutamine, sodium 
butyrate, and dietary interventions, for the prevention or treatment of GIM.84 
Formaldehyde administration should be attempted before surgical therapy. When surgical therapy is 
required, a descending or transverse colostomy must be carried out. Advanced methods such as 
intraperitoneal injections of formalin or novel methods of cold therapy and radiofrequency ablation 
(RFA) provide a wider remedial field. 
Surgical therapy contemplates diversion of the fecal stream via a colostomy or an ileostomy, local 
repair with reconstruction and mobilization of an advanced flap in cases of fistulas and, for more 
severe or refractory cases, proctectomy.85,86  
Since aggressive treatments like coloanal anastomosis and colorectal surgery are correlated with 
remarkable mortality and morbidity, they must be considered as the final course of remedial treatment. 
Radiation injury can be limited through two main strategies: reducing the dose delivered to adjacent 
structures using, for example, intensity-modulated, volumetric-modulated and 3-dimensional 
conformal radiation therapy87 or brachytherapy; reducing the radiosensitivity of the organs at risk, 
using some medications such as amifostine, a prodrug that scavenges oxygen free radicals, used 
intravenously in some randomized trials.88 
 
Surgical diversion 
   First described as a new entity in 1981 by Glotzer et al.,88 diversion proctitis is an inflammatory 
disease involving the excluded rectum, which is diverted from the fecal stream by surgical 
interventions, and is part of the broader spectrum defined as radiation colitis. Its incidence as well as 
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supporting them are very limited. Among the hypothesized models are included: bacterial 
overgrowth, presence of harmful bacteria, toxins or disturbance in the symbiotic relationship between 
luminal bacteria and the mucosal layer and nutritional deficiency.90 Usually, the onset is between 3 
and 36 months after fecal diversion.  
   Endoscopic features are various: erythema, mucous plugs, granularity, friability, blurring of 
vascular pattern, aphthous ulcers, spontaneous bleeding, nodularity, edema, inflammatory polyps, and 
strictures. No pathognomonic signs have been identified up to now and biopsies can reveal lymphoid 
follicular hyperplasia, which is one of the commonest finding, crypt distortion, regenerative 
hyperplasia, Paneth cell metaplasia, thickening of muscularis mucosa, diffuse active mucosal 
inflammation with crypt abscess, ulceration, vacuolar and epithelial degeneration. In most cases, 





   Ischemic involvement of the rectum takes place in 5% of the cases of ischemic colitis. Indeed, in 
75% damage is located in colon and, frequently, in the splenic flexure, because the rectum has a wide 
arterial supply network from the inferior mesenteric, internal iliac, internal pudendal arteries and the 
marginal artery.92 Elderly patients with significant atherosclerotic disease compromising blood flow 
and cardiac risk factors are the subjects most frequently exposed to developing ischemic proctitis.93 
Conditions at risk include those implying the possibility to develop a sudden acute compromise in 
blood flow: previous vascular intervention, aorto-iliac surgery, radiotherapy and hypotensive shock.94 
Spontaneous ischemic proctitis is a very rare event, limited to less than 2% of all cases of ischemic 
colitis. Severity con be various: in transient ischemia damages are generally reversible and limited to 
the superficial mucosal layers, consisting of edema and hemorrhage, but, in prolonged ischemia, 
mucosal necrosis with ulceration and/or perforation may lead to fatal consequences. 
   Clinical presentation is not different from the other etiologies and is often misleading. In support to 
the diagnosis computed tomography (CT) scan can give a contribution of suspicion, but colonoscopy, 
performed within 48 h from the beginning of the symptoms, remains the more reliable tool, allowing, 
also, to do biopsies which are generally useful in confirming diagnosis.95 
   In the early stages of treatment, the most important aspect is monitoring vital parameters and 
restoration of the patient’s blood volume in order to maintain or improve the cardiac output. When 
ischemia is transient this management is generally enough to induce recovery and avoid worsening. 
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Broad-spectrum antibiotics can be necessary in this context. The most severe cases, inducing 
perforation, may require surgical interventions: abdominal perineal resection or, when the lower 
rectum is spared, a low anterior resection, represents the commonest adopted technique.96 
 
Traumatisms 
   Chronic traumatism linked to prolonged and repetitive practice of masturbation with anal objects 
can lead to the appearance of ano-rectal lesions similar to those described for other forms of proctitis. 
In addition to the essential anamnestic information, some features help to depose mainly for a 
traumatic form: tears, abrasions, hematoma, discoloration with tenderness, fissures. Similar speech 
can be made for injuries observed after anal intercourse, fisting, which could also cause rectal 
perforation or a lesion of anal sphincters, and sexual abuse.97 
   
      Conclusions  
 
   Nowadays, it is increasingly more common in a gastroenterological setting, to come across of cases 
of proctitis whose nature is not ascribable to IBD. The clinical and endoscopic characteristics, on 
their own, configure clinical pictures that are difficult to distinguish from one another. When it is 
necessary to exclude all other forms of proctitis for which the anamnestic data plays a fundamental 
role, specifically referring to radiation, diversion, ischemic and traumatic form, the clinician is faced 
with the great chapter of the proctitis of infectious origin. As a matter of fact, in the last years, it has 
been registered a growing incidence of infectious proctitides, particularly in MSM, within the broader 
context of STIs. Although the clinical presentation may be undistinguishable from an ulcerative colitis 
or a Crohn’s disease involving ano-rectal region, the response to standard treatments adopted for IBD 
is inadequate. In order to avoid this kind of mistakes, clinicians are required to proceed in a reasoned 
manner, that is to say starting with the collection of an in-depth medical history aimed at assessing 
life-style, recent traveling and sexual habits, including anal intercourse. In addition, it is essential to 
perform a focused physical examination which can help to highlight salient traits attributable to a 
particular etiology. Based on these findings, it is possible to start an empirical treatment with 
antibiotics or antivirals. Further diagnostic tools may contribute to the diagnosis such as culture, PCR, 
serology and endoscopy. Once an infectious cause has been identified it should be provided 
information to patients about transmission risks to partners and it should be emphasized the 
importance that also partners undergo to investigations, due to the high risk of contagion. It is 
advisable for gastroenterologists to refer to an expert in sexual health and associated infections, in 
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transmitted pathogens should be investigated and a complete screening including HIV, first of all, but 
also hepatitis B (HBV) and hepatitis C (HCV)98 viruses should be taken into consideration. With a 
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